Olvanil: A non-pungent TRPV1 activator has anti-emetic properties in the ferret

Neuropharmacology

Volumn 58, Issue 2, 2010, Pages 383-391

  Chu, Kit Man ^a   Ngan, Man Piu ^a   Wai, Man Keung ^a   Yeung, Chi Kong ^a   Andrews, Paul L R ^a,b   Percie du Sert, Nathalie ^a,b   Rudd, John A ^a  

^a Emesis Research Group   (Hong Kong)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Cisplatin; Emesis; Olvanil; Resiniferatoxin; TRPV1; Vanilloid

Indexed keywords

APOMORPHINE; CISPLATIN; COPPER SULFATE; N (4 HYDROXYPHENYL)ARACHIDONAMIDE; OLVANIL; RESINIFERATOXIN; VANILLOID RECEPTOR 1;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIEMETIC ACTIVITY; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY TEMPERATURE; CONTROLLED STUDY; FERRET; FLUID INTAKE; FOOD INTAKE; HYPERTENSION; HYPOTHERMIA; MALE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR UPREGULATION; TELEMETRY; VOMITING;

ANIMALS; ANTIEMETICS; APOMORPHINE; ARACHIDONIC ACIDS; BEHAVIOR, ANIMAL; BLOOD PRESSURE; BODY TEMPERATURE; CAPSAICIN; CISPLATIN; COPPER SULFATE; DITERPENES; DOSE-RESPONSE RELATIONSHIP, DRUG; FERRETS; HEART RATE; MALE; TRPV CATION CHANNELS; VOMITING;

EID: 72149132254     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2009.10.002     Document Type: Article

References (39)

1. Andrews P.L.R., and Bhandari P. Resinferatoxin, an ultrapotent capsaicin analogue, has anti-emetic properties in the ferret. Neuropharmacology 32 (1993) 799-806
2. Andrews P.L.R., Davis C.J., Bingham S., Davidson H.I.M., Hawthorn J., and Maskell L. The abdominal visceral innervation and the emetic reflex: pathways, pharmacology, and plasticity. Can. J. Physiol. Pharmacol. 68 (1990) 325-345
3. Andrews P.L.R., Dovey E., Hockaday J., Hoyle C.H., Woods A.J., and Matsuki N. The development of the emetic reflex in the house musk shrew, Suncus murinus. Brain Res. Dev. Brain Res. 121 (2000) 29-34
4. Andrews P.L.R., Okada F., Woods A.J., Hagiwara H., Kakaimoto S., Toyoda M., and Matsuki N. The emetic and anti-emetic effects of the capsaicin analogue resiniferatoxin in Suncus murinus, the house musk shrew. Br. J. Pharmacol. 130 (2000) 1247-1254
5. Andrews P.L.R., and Rudd J.A. The role of tachykinins and the tachykinin receptor in nausea and emesis. In: Holzer P. (Ed). Handbook of Experimental Pharmacology (2004), Springer-Verlag Berlin Heidelberg, Berlin, Germany 359-440
6. Appendino G., De Petrocellis L., Trevisani M., Minassi A., Daddario N., Moriello A.S., Gazzieri D., Ligresti A., Campi B., Fontana G., Pinna C., Geppetti P., and Di Marzo V. Development of the first ultra-potent "capsaicinoid" agonist at transient receptor potential vanilloid type 1 (TRPV1) channels and its therapeutic potential. J. Pharmacol. Exp. Ther. 312 (2005) 561-570
7. Beltramo M., and Piomelli D. Anandamide transport inhibition by the vanilloid agonist olvanil. Eur. J. Pharmacol. 364 (1999) 75-78
8. Bowser-Riley F., Cornish M., Kidd C., and Zheng F. Role of vagal afferent C fibres in the bradycardiac response to an increase in arterial blood pressure in ferrets. Exp. Physiol. 75 (1990) 859-862
9. Chahl L.A., and Lynch A.M. The acute effects of capsaicin on the cardiovascular system. Acta Physiol. Hung. 69 (1987) 413-419
10. Costall B., Domeney A.M., Naylor R.J., Owera-Atepo J.B., Rudd J.A., and Tattersall F.D. Fluphenazine, ICS 205-930 and dl-fenfluramine differentially antagonise drug-induced emesis in the ferret. Neuropharmacology 29 (1990) 453-462
11. Darmani N.A., McClanahan B.A., Trinh C., Petrosino S., Valenti M., and Di Marzo V. Cisplatin increases brain 2-arachidonoylglycerol (2-AG) and concomitantly reduces intestinal 2-AG and anandamide levels in the least shrew. Neuropharmacology 49 (2005) 502-513
12. Dekermendjian K., Shan R., Nielsen M., Stadler M., Sterner O., and Witt M.R. The affinity to the brain dopamine D1 receptors in vitro of triprenyl phenols isolated from the fruit bodies of Albatrellus ovinus. Eur. J. Med. Chem. 32 (1997) 351-356
13. Dray A., and Dickenson A. Systemic capsaicin and olvanil reduce the acute algogenic and the late inflammatory phase following formalin injection into rodent paw. Pain 47 (1991) 79-83
14. Geraghty D.P., and Mazzone S.B. Respiratory actions of vanilloid receptor agonists in the nucleus of the solitary tract: comparison of resiniferatoxin with non-pungent agents and anandamide. Br. J. Pharmacol. 137 (2002) 919-927
15. Hillard C.J., Shi L., Tuniki V.R., Falck J.R., and Campbell W.B. Studies of anandamide accumulation inhibitors in cerebellar granule neurons: comparison to inhibition of fatty acid amide hydrolase. J. Mol. Neurosci. 33 (2007) 18-24
16. Holmes A.M., Rudd J.A., Tattersall F.D., and Andrews P.L.R. Opportunities for the replacement of animals in the study of nausea and vomiting. Br. J. Pharmacol. 157 (2009) 865-880
17. Iida T., Moriyama T., Kobata K., Morita A., Murayama N., Hashizume S., Fushiki T., Yazawa S., Watanabe T., and Tominaga M. TRPV1 activation and induction of nociceptive response by a non-pungent capsaicin-like compound, capsiate. Neuropharmacology 44 (2003) 958-967
18. Jonassohn M., Hjertberg R., Anke H., Dekermendjian K., Szallasi A., Thines E., Witt R., and Sterner O. The preparation and bioactivities of (-)-isovelleral. Bioorg. Med. Chem. 5 (1997) 1363-1367
19. Kan K.K.W., Ngan M.P., Wai M.K., and Rudd J.A. Mechanism of the TP receptor agonist U46619 for inducing emesis in the ferret. Nauyn-Schmied. Arch. Pharmacol. 378 (2008) 655-661
20. Knox A.P., Strominger N.L., Battles A.H., and Carpenter D.O. Behavioral studies of emetic sensitivity in the ferret. Brain Res. Bull. 31 (1993) 477-484
21. La Rana G., Russo R., Campolongo P., Bortolato M., Mangieri R.A., Cuomo V., Iacono A., Raso G.M., Meli R., Piomelli D., and Calignano A. Modulation of neuropathic and inflammatory pain by the endocannabinoid transport inhibitor AM404 [N-(4-hydroxyphenyl)-eicosa-5,8,11,14-tetraenamide]. J. Pharmacol. Exp. Ther. 317 (2006) 1365-1371
22. Lau A.H.Y., Ngan M.P., Rudd J.A., and Yew D.T.W. Differential action of domperidone to modify emesis and behaviour induced by apomorphine in the ferret. Eur. J. Pharmacol. 516 (2005) 247-252
23. Movahed P., Evilevitch V., Andersson T.L.G., Jönsson A.G., Wollmer P., Zygmunt P.M., and Högestätt E.D. Vascular effects of anandamide and N-acylvanillylamines in the human forearm and skin microcirculation. Br. J. Pharmacol 146 (2005) 171-179
24. Pilowsky P.M., and Goodchild A.K. Baroreceptor reflex pathways and neurotransmitters: 10 years on. J. Hypertens. 20 (2002) 1675-1688
25. Ross R.A. Anandamide and vanilloid TRPV1 receptors. Br. J. Pharmacol. 140 (2003) 790-801
26. Rudd J.A., and Andrews P.L.R. Mechanisms of acute, delayed and anticipatory vomiting in cancer and cancer treatment. In: Hesketh P. (Ed). Management of Nausea and Vomiting in Cancer and Cancer Treatment (2004), Jones and Barlett Publishers Inc., New York 15-66
27. Rudd J.A., and Wai M.K. Genital grooming and emesis induced by vanilloids in Suncus murinus, the house musk shrew. Eur. J. Pharmacol. 422 (2001) 185-195
28. Sharkey K.A., Cristino L., Oland L.D., Van Sickle M.D., Starowicz K., Pittman Q.J., Guglielmotti V., Davison J.S., and Di Marzo V. Arvanil, anandamide and N-arachidonoyl-dopamine (NADA) inhibit emesis through cannabinoid CB1 and vanilloid TRPV1 receptors in the ferret. Eur. J. Neurosci. 25 (2007) 2773-2782
29. Shiroshita Y., Koga T., and Fukuda H. Capsaicin in the 4th ventricle abolishes retching and transmission of emetic vagal afferents to solitary nucleus neurons. Eur. J. Pharmacol. 339 (1997) 183-192
30. Szallasi A. Vanilloid receptor ligands: hopes and realities for the future. Drugs Aging 18 (2001) 561-573
31. Szallasi A., and Blumberg P.M. Vanilloid receptors: new insights enhance potential as a therapeutic target. Pain 68 (1996) 195-208
32. Szallasi A., and Blumberg P.M. Vanilloid (Capsaicin) receptors and mechanisms. Pharmacol. Rev. 51 (1999) 159-212
33. 1 receptor antagonists act centrally to inhibit emesis induced by the chemotherapeutic agent cisplatin in ferrets. Neuropharmacology 35 (1996) 1121-1129
34. Uchino M., Kuwahara M., Ebukuro S., and Tsubone H. Modulation of emetic response by carotid baro- and chemoreceptor activations. Auton. Neurosci. 128 (2006) 25-36
35. Wan C., and Rudd J.A. The emetic, hypothermic, and anti-emetic actions of centrally administered vanilloids in Suncus murinus. J. Pharmacol. Sci. 94 Suppl. 1 (2004) 96
36. 1 receptor. Br. J. Pharmacol. 115 (1995) 84-94
37. 3A receptors varies with receptor density and desensitization. Mol. Pharmacol. 73 (2008) 314-322
38. Yamakuni H., Sawai-Nakayama H., Imazumi K., Maeda Y., Matsuo M., Manda T., and Mutoh S. Resiniferatoxin antagonizes cisplatin-induced emesis in dogs and ferrets. Eur. J. Pharmacol. 442 (2002) 273-278
39. 3 receptors in the area postrema in R(+)-7-OH-DPAT-induced emesis in the ferret. Eur. J. Pharmacol. 301 (1996) 143-149